News

New publication in MABS 2024

12 December 2023

Sciences

Structural analysis of light chain-driven bispecific antibodies targeting CD47 andPD-L1

Read more: New publication in MABS 2024

7th Annual Immuno-Oncology Summit Europe 2023

19 June 2023

Events

Antibody Engineering & Therapeutics Europe- Sara Majocchi -

Read more: 7th Annual Immuno-Oncology Summit Europe 2023

Two Light chain Bioscience presentations at Antibody Engineering & Therapeutics Europe

01 June 2023

Events

Antibody Engineering & Therapeutics Europe - Nicolas Fischer & Sara Majocchi -

Read more: Two Light chain Bioscience presentations at Antibody Engineering & Therapeutics Europe

PEGS Boston – Advancing Bispecific Antibodies and Combination Therapy to the Clinic

01 May 2023

Events

19th annual PEGS Boston - Nicolas Fischer -

Read more: PEGS Boston – Advancing Bispecific Antibodies and Combination Therapy to the Clinic

AACR-2023 NI-2901 (CD47xPD-L1) & NI-3201 (CD28xPD-L1) bispecific antibodies

17 April 2023

Events

AACR Annual Meeting 2023 - Walter Ferlin & Xavier Chauchet -

Read more: AACR-2023 NI-2901 (CD47xPD-L1) & NI-3201 (CD28xPD-L1) bispecific antibodies

New publication in Molecular Therapy

Written by Remi Jeandenand on Tuesday, 03 November 2026. Posted in News

LinkedIn

N
E
W
S